Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: Study in 200 consecutively recruited individuals

Stroke

Volumn 41, Issue 4, 2010, Pages 630-634

  Adib Samii, Poneh ^a   Brice, Glen ^b   Martin, Roswell J ^a,c   Markus, Hugh S ^a  

^a Clinical Neurosciences   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

CADASIL; Hypertension; Phenotype; Risk factors; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CYSTEINE; GLYCINE; HYPOCHOLESTEROLEMIC AGENT; NOTCH3 RECEPTOR; THREONINE; WARFARIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN DISEASE; BRAIN HEMORRHAGE; CADASIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DEPRESSION; DIABETES MELLITUS; EXON; FAMILY; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE AURA; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SMOKING; STROKE; SYMPTOM; UNITED KINGDOM;

ADOLESCENT; ADULT; CADASIL; CARDIOVASCULAR DISEASES; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MENTAL DISORDERS; MIDDLE AGED; MIGRAINE DISORDERS; PHENOTYPE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 77950273952     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.568402     Document Type: Article

References (24)

1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Maréchal E, Maciazek J, Vayssière C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707-710.
2. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999;30:1230-1233.
3. Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731-739.
4. Mykkänen K, Junna M, Amberla K, Bronge L, Kääriäinen H, Pöyhönen M, Kalimo H, Viitanen M. Different clinical phenotypes in monozygotic CADASIL twins with a novel NOTCH3 mutation. Stroke. 2009;40: 2215-2218.
5. Opherk C, Peters N, Holtmannspötter M, Gschwendtner A, Müller-Myhsok B, Dichgans M. Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke. 2006;37:2684-2689.
6. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127:2031-2038.
7. Holtmannspötter M, Peters N, Opherk C, Martin D, Herzog J, Brückmann H, Sämann P, Gschwendtner A, Dichgans M. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a 2-year follow-up study. Stroke. 2005;36: 2559-2565.
8. Peters N, Holtmannspötter M, Opherk C, Gschwendtner A, Herzog J, Sämann P, Dichgans M. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology. 2006;66:1517-1522.
9. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF. Diagnostic strategies in CADASIL. Neurology. 2002;59:1134-1138.
10. Mayer M, Straube A, Bruening R, Uttner I, Pongratz D, Gasser T, Dichgans M, Müller-Höcker J. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol. 1999;246: 526-532.
11. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
12. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
13. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J. 1987;8:77-88.
14. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
15. Zaudig M. A new systematic method of measurement and diagnosis of 'mild cognitive impairment' and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr. 1992;4(suppl 2):203-219.
16. Schon F, Martin RJ, Prevett M, Clough C, Enevoldson TP, Markus HS. 'CADASIL coma': an underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry. 2003;74:249-252
17. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: II edition. Cephalalgia. 2004;24(suppl 1):9-160.
18. Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:57-59.
19. Maclean AV, Woods R, Alderson LM, Salloway SP, Correia S, Cortez S, Stopa EG. Spontaneous lobar haemorrhage in CADASIL. J Neurol Neu-rosurg Psychiatry. 2005;76:456-457.
20. Lee YC, Liu CS, Chang MH, Lin KP, Fuh JL, Lu YC, Liu YF, Soong BW. Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol. 2009;256:249-255.
21. Choi JC, Kang SY, Kang JH, Park JK. Intracerebral hemorrhages in CADASIL. Neurology. 2006;67:2042-2044.
22. Lesnik Oberstein SA, van den Boom R, van Buchem MA, van Hou-welingen HC, Bakker E, Vollebregt E, Ferrari MD, Breuning MH, Haan J. Dutch CADASIL Research Group. Cerebral microbleeds in CADASIL. Neurology. 2001;57:1066-1070.
23. Charlton RA, Morris RG, Nitkunan A, Markus HS. The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology 2006;66: 1523-1526.
24. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127:2533-2539.